Aetions Medical Evidence Software Scores $11M in Funding

As healthcare payment models change in ways that link the reimbursement of care to patient outcome, clinicians, drug companies, and medical device makers are all looking for ways to quantify those outcomes. Health IT startup Aetion has developed software that it says can provide this insight, and the company now has $11 million in capital to support its efforts.

Flare Capital Partners led the Series A investment round in New York-based Aetion. Lakestar also participated in the financing.

Aetion says its technology, called the Aetion Evidence Platform, analyzes clinical and financial interactions to find evidence about the effectiveness and value of medical treatments. The company, which counts life science companies and insurance companies as customers, says that users can work with the software to determine medical need, comparative effectiveness, and the value of a particular treat...